Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
RC Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
RC Capital

RC Capital

Operating

RC Capital, a growth equity firm, builds high-potential healthcare companies, focusing on medical devices, healthcare services, and IT.

Location
Cincinnati, OH, US
Founded
1994
Firm
Compare
Portfolio
Employees
Website

Investments

SPR Therapeutics
SPR Therapeutics

Total Raised

$188.8M

Rounds

14

Series D$25MFebruary 2024
Series D$37MOctober 2021
ModifyHealth
ModifyHealth

Total Raised

$14M

Rounds

3

Series B$10MJanuary 2023
Nico
Nico

Total Raised

$68.1M

Rounds

8

Series Unknown$12.6MOctober 2022
Series Unknown$15MFebruary 2016
Catalyst OrthoScience
Catalyst OrthoScience

Total Raised

$46M

Rounds

5

Series D$12.3MOctober 2021
Series C$12.7MMay 2019
Checkpoint Surgical
Checkpoint Surgical

Total Raised

$44.7M

Rounds

8

Series Unknown$16MAugust 2021
Q'Apel Medical
Q'Apel Medical

Total Raised

$51.9M

Rounds

2

Series C$22MFebruary 2021
Omnia Partners
Omnia Partners

Rounds

2

Private EquityJanuary 2020
Reputation.com
Reputation.com

Total Raised

$210.6M

Rounds

4

Series C$34.9MAugust 2019
Series B$3.8MFebruary 2018
Faction
Faction

Total Raised

$62M

Rounds

7

Series B$14MApril 2019
Series B$18MMarch 2018
Liquibase
Liquibase

Total Raised

$27M

Rounds

8

Series C$10MFebruary 2019
Orthalign
Orthalign
Public

Total Raised

$55.8M

Rounds

7

Series D$10MSeptember 2017
Series C$15MNovember 2014
Netsertive
Netsertive

Total Raised

$41M

Rounds

5

Series C$24MOctober 2015
PerfectServe
PerfectServe

Total Raised

$35.9M

Rounds

7

Series D$21MSeptember 2015
Series C$10.9MFebruary 2012
Reveal Mobile
Reveal Mobile

Total Raised

$7.9M

Rounds

7

Pre-Seed$1.3MJuly 2015
BioTissue
BioTissue
Public

Total Raised

$110M

Rounds

5

Series B$15MJune 2015
Series A$10MAugust 2013
Continuity
Continuity

Total Raised

$21.5M

Rounds

7

Series Unknown$10MAugust 2014
ABT Molecular Imaging
ABT Molecular Imaging

Total Raised

$28.4M

Rounds

10

Series C$6MSeptember 2012